New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 10, 2014
08:03 EDTCSIICardiovascular Systems receives FDA clearance for Diamondback 360 OAS
Cardiovascular Systems has received FDA clearance of its new Diamondback 360 60cm Peripheral Orbital Atherectomy Systems for the treatment of peripheral arterial disease.
News For CSII From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 23, 2015
07:43 EDTCSIICMS panel removes Cardiovascular Systems overhang, says Leerink
Leerink analyst Danielle Antalffy says the CMS Medicare Evidence Development & Coverage Advisory Committee panel on peripheral arterial disease removes a near-term overhang on shares of Cardiovascular Systems. The company should return to 20%-plus growth with both outpatient reimbursement and CMS panel risk now addressed, Antalffy tells investors in a research note. She keeps an Outperform rating on the stock with a $45 price target.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use